Trial Profile
Disease Modification in Sjogrens Syndrome Measured by Ultrasound: A Pilot Study
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 05 May 2023
Price :
$35
*
At a glance
- Drugs Abatacept (Primary) ; Abatacept (Primary)
- Indications Sjogren's syndrome
- Focus Therapeutic Use
- 10 May 2021 Status changed from recruiting to active, no longer recruiting.
- 22 Oct 2020 Planned End Date changed from 1 Dec 2019 to 1 Dec 2021.
- 22 Oct 2020 Planned primary completion date changed from 1 May 2019 to 1 May 2021.